BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30343377)

  • 1. Defecatory dysfunction and other clinical variables are predictors of pessary discontinuation.
    Dengler EG; Mounsey LA; Gines F; Agha M; Long T; Geller EJ
    Int Urogynecol J; 2019 Jul; 30(7):1111-1116. PubMed ID: 30343377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse.
    Mao M; Ai F; Kang J; Zhang Y; Liang S; Zhou Y; Zhu L
    Menopause; 2019 Feb; 26(2):145-151. PubMed ID: 30130292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.
    Yimphong T; Temtanakitpaisan T; Buppasiri P; Chongsomchai C; Kanchaiyaphum S
    Int Urogynecol J; 2018 Aug; 29(8):1123-1128. PubMed ID: 28815277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term adherence to pessary use in women with pelvic organ prolapse: A retrospective cohort study.
    Koch M; Carlin G; Lange S; Umek W; Krall C; Bodner-Adler B
    Maturitas; 2023 Dec; 178():107828. PubMed ID: 37659128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the symptoms and quality of life of women with symptomatic pelvic organ prolapse fitted with a ring with support pessary.
    Mao M; Ai F; Zhang Y; Kang J; Liang S; Xu T; Zhu L
    Maturitas; 2018 Nov; 117():51-56. PubMed ID: 30314561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ring pessary for all pelvic organ prolapse.
    Manchana T
    Arch Gynecol Obstet; 2011 Aug; 284(2):391-5. PubMed ID: 20848116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between fecal incontinence, constipation and defecatory symptoms in women with pelvic floor disorders.
    Andy UU; Harvie HS; Pahwa AP; Markland A; Arya LA
    Neurourol Urodyn; 2017 Feb; 36(2):495-498. PubMed ID: 26828646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with long-term pessary use in women with symptomatic pelvic organ prolapse.
    Mao M; Xu T; Kang J; Zhang Y; Ai F; Zhou Y; Zhu L
    Climacteric; 2019 Oct; 22(5):478-482. PubMed ID: 30897024
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaginal pessaries for treatment of pelvic organ prolapse in elderly women.
    Griebling TL
    Curr Opin Urol; 2016 Mar; 26(2):201-6. PubMed ID: 26765048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of pessary use in women aged 65 - 74 versus 75 years and older with pelvic organ prolapse: a 12-year study.
    Ramsay S; Tu le M; Tannenbaum C
    Int Urogynecol J; 2016 Aug; 27(8):1201-7. PubMed ID: 26872647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to support pessary in the treatment of pelvic organ prolapse: a retrospective study conducted among 1,371 women.
    Brandt CH; Yamolaei M; Wu C; Hansen UD; Rasch V
    Int Urogynecol J; 2024 Jan; 35(1):69-75. PubMed ID: 37548745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A predictive model of choosing pessary type for women with symptomatic pelvic organ prolapse.
    Xu H; Wu W; Wang X; Xia Z
    Menopause; 2021 Oct; 28(11):1279-1286. PubMed ID: 34636355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing long-term pessary use.
    Friedman S; Sandhu KS; Wang C; Mikhail MS; Banks E
    Int Urogynecol J; 2010 Jun; 21(6):673-8. PubMed ID: 20062974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal ring pessary use for pelvic organ prolapse: continuation rates and predictors of continued use.
    Manonai J; Sarit-Apirak S; Udomsubpayakul U
    Menopause; 2018 Dec; 26(6):665-669. PubMed ID: 30562318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a pessary in treatment of pelvic organ prolapse: quality of life, compliance, and failure at 1-year follow-up.
    Ko PC; Lo TS; Tseng LH; Lin YH; Liang CC; Lee SJ
    J Minim Invasive Gynecol; 2011; 18(1):68-74. PubMed ID: 21195956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line treatment of pelvic organ prolapse and discontinuation of pessary treatment.
    Umachanger JK; Marcussen ML; Bøggild H; Kjærgaard N; Glavind K
    Int Urogynecol J; 2020 Sep; 31(9):1813-1819. PubMed ID: 32447418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical use of ring with support pessary for advanced pelvic organ prolapse and predictors of its short-term successful use.
    Deng M; Ding J; Ai F; Zhu L
    Menopause; 2017 Aug; 24(8):954-958. PubMed ID: 28419067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for unsuccessful pessary fitting in women with symptomatic pelvic organ prolapse: a prospective study.
    Mao M; Ai F; Zhang Y; Kang J; Liang S; Xu T; Zhu L
    BJOG; 2018 Oct; 125(11):1434-1440. PubMed ID: 29700950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term compliance of vaginal pessaries: Does stress urinary incontinence matter?
    Hsieh MF; Tsai HW; Liou WS; Lo CC; Lin ZH; An YF; Lin HY
    Medicine (Baltimore); 2019 Apr; 98(14):e15063. PubMed ID: 30946355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ring and Gellhorn pessaries used in patients with pelvic organ prolapse: a retrospective study of 8 years.
    Yang J; Han J; Zhu F; Wang Y
    Arch Gynecol Obstet; 2018 Sep; 298(3):623-629. PubMed ID: 29978415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.